Use of vancomycin powder in spinal deformity surgery in cerebral palsy patients is associated with proteus surgical site infections

for Harms Study Group

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Surgical site infection (SSI) rates in pediatric spinal deformity surgery for cerebral palsy (CP) patients are higher than that in idiopathic scoliosis. The use of vancomycin powder is associated with decreased risk of SSI in neuromuscular patients. Prior studies in adult and pediatric early-onset scoliosis patients have shown that vancomycin powder alters microbacterial profile in patients that develop SSI. However, the effects of topical vancomycin powder on microbiology in spinal deformity surgery for CP patients has not been studied. Methods: An international multicenter database of CP neuromuscular scoliosis patients was used in this retrospective cohort study. All patients that underwent posterior spinal instrumented fusion for CP neuromuscular scoliosis from 2008 to 2019 were queried, and 50 cases complicated by postoperative SSI were identified. Intraoperative antibiotic details were documented in 49 cases (98.0%). Microbiology details were documented in 45 cases (91.8%). Microbiology for patients that received topical vancomycin powder were compared with patients that did not. A multivariate regression model was used to control for potential confounders. Results: There were 45 patients included in this study. There were 27 males (60.0%) and 18 females (40.0%). Mean age at surgery was 14.8 ± 2.4 years. There were 24 patients that received topical vancomycin powder (53.3%). The mean time from index surgery to SSI was 4.3 ± 11.3 months. On univariate analysis of microbiology cultures by vancomycin powder cohort, there were no significant differences in culture types. Proteus spp. trended on significance with association with vancomycin powder use (P = 0.078). When controlling for potential confounders on multivariate analysis, intraoperative topical vancomycin powder was associated with increased risk for proteus infection (adjusted odds ratio: 262.900, 95% confidence interval: 1.806-38,267.121, P = 0.028). Discussion: In CP patients undergoing pediatric spinal deformity surgery, the use of vancomycin powder was independently associated with increased risk for proteus infections. Further study into antibiotic regimens for spinal deformity surgery in the CP population should be performed.

Original languageEnglish
Pages (from-to)280-284
Number of pages5
JournalJournal of Pediatric Orthopaedics
Volume42
Issue number5
DOIs
StatePublished - 1 May 2022

Keywords

  • Cerebral palsy
  • Infection
  • Neuromuscular scoliosis
  • Prophylaxis
  • Proteus
  • Vancomycin powder

Fingerprint

Dive into the research topics of 'Use of vancomycin powder in spinal deformity surgery in cerebral palsy patients is associated with proteus surgical site infections'. Together they form a unique fingerprint.

Cite this